Etomoxir-carnitine, a Novel Pharmaco-metabolite of Etomoxir, Inhibits Phospholipases A2 and Mitochondrial Respiration

September 1, 2024

By Moon SH, Liu X, Jenkins CM, Dilthey BG, Patti GJ, and Gross RW

Journal of Lipid Research, in press, 2024